The NYT has an article reporting on how test results on Zetia, a new cholesterol lowering drug, were hidden or misrepresented. It never mentions the incentives given by patent protection for this sort of corruption. There are alternatives to patent protection for financing drug research. It is remarkable that this never gets mentioned in news reporting. The distortions created by patent protection for prescription drugs dwarf the distortions created by the protectionist measures that "free traders" focus their sights on.
Unlike many news organizations, the Prospect has remained staunchly committed to keeping our journalism free and accessible to all. We believe that independent journalism is crucial for a functioning democracy—but quality reporting comes at a cost.
This year, we’re aiming to raise $75,000 to continue delivering the hard-hitting investigative journalism you’ve come to expect from us. Your support helps us maintain our independence and dig deeper into the stories that matter most.
If you value our reporting, please consider making a contribution today. Any amount helps secure our future and ensure we can continue holding power to account.